News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Foundation Medicine Sets Terms for $75 Million IPO



9/13/2013 10:32:35 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Foundation Medicine, which develops diagnostic systems that assess genomic alterations in cancer cells and match patients with targeted therapies, announced terms for its IPO on Thursday. The Cambridge, MA-based company plans to raise $75 million by offering 5.0 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Foundation Medicine would command a fully diluted market value of $421 million.

Help employers find you! Check out all the jobs and post your resume.

Read at Nasdaq


comments powered by Disqus
Nasdaq
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES